Sampogna G, Di Vincenzo M, Giuliani L, Menculini G, Mancuso E, Arsenio E
Brain Sci. 2023; 13(11).
PMID: 38002537
PMC: 10669728.
DOI: 10.3390/brainsci13111577.
Szmyd J, Lewczuk K, Teopiz K, McIntyre R, Wichniak A
Brain Sci. 2023; 13(3).
PMID: 36979199
PMC: 10046273.
DOI: 10.3390/brainsci13030389.
Hanifi Kokacya M, Virit O, Copoglu U, Savas H, Ari M, Bahceci B
Noro Psikiyatr Ars. 2017; 53(4):328-333.
PMID: 28360807
PMC: 5353039.
DOI: 10.5152/npa.2016.11327.
Liang S, Deng W, Wang Q, Ma X, Li M, Brown M
Sci Rep. 2016; 6:32597.
PMID: 27581658
PMC: 5007652.
DOI: 10.1038/srep32597.
Revicki D, Kleinman L, Cella D
Dialogues Clin Neurosci. 2014; 16(2):127-35.
PMID: 25152652
PMC: 4140507.
The impact of skills training on cognitive functioning in older people with serious mental illness.
Pratt S, Mueser K, Bartels S, Wolfe R
Am J Geriatr Psychiatry. 2013; 21(3):242-50.
PMID: 23395191
PMC: 3529976.
DOI: 10.1097/JGP.0b013e31826682dd.
Schizophrenia and quality of life: how important are symptoms and functioning?.
Galuppi A, Turola M, Nanni M, Mazzoni P, Grassi L
Int J Ment Health Syst. 2010; 4:31.
PMID: 21143871
PMC: 3016370.
DOI: 10.1186/1752-4458-4-31.
Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis.
Meyer U, Knuesel I, Nyffeler M, Feldon J
Psychopharmacology (Berl). 2009; 208(4):531-43.
PMID: 20041229
DOI: 10.1007/s00213-009-1754-6.
Schizophrenia: Impact on quality of life.
Solanki R, Singh P, Midha A, Chugh K
Indian J Psychiatry. 2009; 50(3):181-6.
PMID: 19742235
PMC: 2738356.
DOI: 10.4103/0019-5545.43632.
Determinants of objective and subjective quality of life in first-time-admission schizophrenic patients in Poland: a longitudinal study.
Gorna K, Jaracz K, Rybakowski F, Rybakowski J
Qual Life Res. 2007; 17(2):237-47.
PMID: 18163221
DOI: 10.1007/s11136-007-9296-z.
Substance abuse and quality of life among severely mentally ill consumers: a longitudinal modelling analysis.
Urbanoski K, Cairney J, Adlaf E, Rush B
Soc Psychiatry Psychiatr Epidemiol. 2007; 42(10):810-8.
PMID: 17660931
DOI: 10.1007/s00127-007-0236-6.
Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis.
Eack S, Newhill C
Schizophr Bull. 2007; 33(5):1225-37.
PMID: 17204532
PMC: 2632363.
DOI: 10.1093/schbul/sbl071.
Psychomotor slowing in schizophrenia.
Morrens M, Hulstijn W, Sabbe B
Schizophr Bull. 2006; 33(4):1038-53.
PMID: 17093141
PMC: 2632327.
DOI: 10.1093/schbul/sbl051.
Quality of life of mental health consumers in Hong Kong: Analysis of service perceptions.
Wu C, Mak W, Wan D
Qual Life Res. 2006; 16(1):31-40.
PMID: 17033904
DOI: 10.1007/s11136-006-9104-1.
Clinical characteristics and objective living conditions in relation to quality of life among community-based individuals of schizophrenia in Hong Kong.
Yeung F, Chan S
Qual Life Res. 2006; 15(9):1459-69.
PMID: 16957873
DOI: 10.1007/s11136-006-0006-z.
Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment.
Matza L, Buchanan R, Purdon S, Brewster-Jordan J, Zhao Y, Revicki D
Schizophr Bull. 2006; 32(4):666-78.
PMID: 16829550
PMC: 2632260.
DOI: 10.1093/schbul/sbl004.
Quality of life and temperament factors in schizophrenia: comparative study of patients, their siblings and controls.
Kurs R, Farkas H, Ritsner M
Qual Life Res. 2005; 14(2):433-40.
PMID: 15892432
DOI: 10.1007/s11136-004-0799-6.
Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement.
Molina V, Gispert J, Reig S, Sanz J, Pascau J, Santos A
Psychopharmacology (Berl). 2004; 178(1):17-26.
PMID: 15365682
DOI: 10.1007/s00213-004-1981-9.
Cognitive effects of olanzapine treatment in schizophrenia.
McGurk S, Lee M, Jayathilake K, Meltzer H
MedGenMed. 2004; 6(2):27.
PMID: 15266253
PMC: 1395781.
[Comparative study of life quality in patients with cycloid and schizophrenic psychoses].
Jabs B, Krause U, Althaus G, Stober G, Pfuhlmann B
Nervenarzt. 2004; 75(5):460-6.
PMID: 15252886
DOI: 10.1007/s00115-003-1591-5.